Question Bank › External validation gate just cleared

External validation gate just cleared

Calls Tested
499
Answered YES
9
Hit Rate
1.8%
rare by design

Green Brick Partners, Inc. (GRBK) — this company's answers

NO on the Q3 2023 call 2023-11-01 B

← Back to the full GRBK analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management report that the company has JUST CLEARED, or is at the very threshold of clearing, a major external validation gate that stands between its key product or offering and real commercialization — such as a regulatory approval or clearance, a certification or qualification by a major partner, customer, or authority, a successful pivotal study or field trial, a first flagship customer or deployment going live, or a key product finally moving from development into genuine commercial availability — AND does management frame this event as opening the door to a substantially larger commercial opportunity than the company's current sales reflect? Answer YES when the gate-clearing is presented as a recently achieved or imminently completing fact (not a distant hope), and management treats it as the pivotal unlock for commercialization or broad adoption, in whatever form fits the business. Answer NO if the milestone is only aspirational, early-stage, or far in the future; NO if the event is a routine product update, ordinary contract win, or incremental feature release within an already-commercialized business; NO if management does not connect the event to a meaningfully larger opportunity ahead; and NO if the milestone is mentioned only by an analyst without management confirming it. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
GPRE Green Plains Inc. Q4 2023 2024-02-07 F
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
PRPO Precipio, Inc. Q3 2018 2018-11-19 D
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
INSM Insmed Incorporated Q4 2017 2018-02-23 B
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
WYY WidePoint Corporation Q3 2016 2016-11-09 D
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

More from the question bank

Customers changing how they buyFixed-cost base already built, incremental vFrom bespoke to repeatable playbookCapacity committed ahead of demandGrowth engine outrunning the legacy coreNewly signed enterprise contracts forcing a All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.